Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CGT4859 |
Synonyms | |
Therapy Description |
CGT4859 is a selective reversible inhibitor of FGFR2 and FGFR3, with activity against mutant FGFR2, which potentially reduces proliferation of tumor cells overexpressing FGFR2 or FGFR3 (Cancer Res (2025) 85 (8_Supplement_1): 4729, NCI Drug Dictionary). |